Insider filing · TVTX
Jeffrey A Meckler
Director
profile →
Travere Therapeutics, Inc.
TVTX · Healthcare · 74 filings in 24 months
ticker →
Jeffrey A Meckler sold $360K of Travere Therapeutics (TVTX)
Executed May 4, disclosed May 6, 2 days later.
Value, as filed
$360K
8,000 sh × $45.00
Executed
May 4
the trade date, as filed
Disclosed
May 6
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JMJeffrey A Meckler (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $1.3M of TVTX (18,800 sh across 3 lots, as filed), executed Sep 10.
The name
TVTXHealthcare · Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jeffrey A Meckler in TVTX
TVTXSALE
Travere Therapeutics, Inc.
$1.3M18,800 sh across 3 lots
Exec Sep 10
Filed Sep 11 · 4:05 PM ET TVTXSALE Travere Therapeutics, Inc. $562K
40,000 sh × $14.06
Exec Sep 30 2024
Filed Sep 30 2024 · 5:30 PM ET